Jeremy Ahouse serves as VP of Alliance Management for Pioneering Medicines, a unit within Flagship Pioneering focused on creating innovative treatments by leveraging Flagship's ecosystem of bioplatform companies. With over two decades working with research and early development teams in biotech/pharma alliances, Jeremy joined Flagship in 2024 after roles at Merus, Celgene, Novartis, ImmunoGen, Vantage Partners, and Millennium. He earned his PhD in molecular immunology and biophysics and did a HHMI postdoc in Developmental Genetics. Jeremy's extensive experience includes serving on the board of the Association of Strategic Alliance Professionals (ASAP). He specializes in multi-party agreements with a focus on how collaborations can enhance scientific creativity.